Andrew Garner’s Post

🚨 Big Moves in Medtech 🚨 Edwards Lifesciences, a key player in the cardiovascular space, is restructuring its strategy with a 10% reduction in its workforce and the sale of its critical care business. This shift aims to optimize operations and refocus on core growth areas following a period of underperformance. What does this mean for the industry? 🤔 The changes could potentially reshape critical care technology, paving the way for new innovations and collaborations. This move highlights the ever-evolving nature of the medtech sector, emphasizing the importance of adaptability for companies to thrive in a competitive landscape. Stay updated on how these adjustments may impact market trends and future advancements in cardiovascular technology. 📉 #Medtech #Healthcare #Innovation #EdwardsLifesciences #CriticalCare

Keely Flood

Learn how to increase your recruitment revenue, eliminate inconsistent results, and scale systematically. | Reserve your January cohort spot (5/12 spots filled thus far)

3mo

Is it public knowledge who they are selling their critical care unit to?

Like
Reply

To view or add a comment, sign in

Explore topics